Premier Greg Selinger, and Healthy Living, Seniors and Consumer Affairs Minister Jim Rondeau celebrate with the Premier’s Healthy Living Award for Youth winners.
Premier Greg Selinger and Healthy Living, Seniors and Consumer Affairs Minister Jim Rondeau presented 10 outstanding Grade 12 students with the Premier’s Healthy Living Award for Youth at a ceremony at the Legislative Building today.
“Every one of these students has shown dedication and commitment to make their schools and communities better,” said Selinger. “We want to commend their efforts and encourage others to follow their lead, as they demonstrate the future of Manitoba is in good hands.”
This year’s recipients of healthy living awards are:
“It is great to see the energy and enthusiasm of students like these and they are role models for their peers and all Manitobans,” said Rondeau. “These young people are leading the way for their generation to achieve a healthy, active lifestyle.”
Offered through Manitoba’s Healthy Schools Initiative, the Premier’s Healthy Living Award for Youth has recognized more than 30 Manitoba youth for their volunteer contributions in areas such as active living, healthy eating, healthy sexuality, mental health promotion, safety and injury prevention, substance use and addiction, and tobacco reduction.
“Every one of these students has shown dedication and commitment to make their schools and communities better,” said Selinger. “We want to commend their efforts and encourage others to follow their lead, as they demonstrate the future of Manitoba is in good hands.”
This year’s recipients of healthy living awards are:
- Kylie Bard, Miles Macdonell Collegiate, Winnipeg;
- Rachel Ashley Byrka, Miami School, Miami;
- Janelle Chilton, River East Collegiate, Winnipeg;
- Nicole Kinglsey, Dauphin Regional Comprehensive Secondary School, Dauphin;
- Alexa Lecomte, St. Mary’s Academy, Winnipeg;
- Rhiannon McConnell-Hore, Margaret Barbour Collegiate Institute, The Pas;
- Rebecca Reis, Vincent Massey Collegiate, Winnipeg;
- Jodi Ruchkall, Niverville Collegiate Institute, Niverville;
- Claire Russell, Vincent Massey Collegiate, Winnipeg; and
- Yushi (Wendy) Wang, Kelvin High School, Winnipeg.
“It is great to see the energy and enthusiasm of students like these and they are role models for their peers and all Manitobans,” said Rondeau. “These young people are leading the way for their generation to achieve a healthy, active lifestyle.”
Offered through Manitoba’s Healthy Schools Initiative, the Premier’s Healthy Living Award for Youth has recognized more than 30 Manitoba youth for their volunteer contributions in areas such as active living, healthy eating, healthy sexuality, mental health promotion, safety and injury prevention, substance use and addiction, and tobacco reduction.
(l to r) Intelligent Hospital Systems president and CEO Niels Erik Hansen, Entrepreneurship, Training and Trade Minister Peter Bjornson and CancerCare Manitoba CEO Dhali Dhaliwal pictured with the RIVA system—new, state-of-the-art technology that will prepare chemotherapy drugs for CancerCare Manitoba safely and accurately.
June 13, 2013
Advanced, High-tech System will Reduce Risk of Error, Increase Productivity: Oswald, Bjornson
A new, state-of-the-art system developed by a Winnipeg-based company will prepare chemotherapy drugs with a high degree of precision, helping CancerCare Manitoba enhance patient and staff safety, Health Minister Theresa Oswald and Entrepreneurship, Training and Trade Minister Peter Bjornson announced today.
“The new RIVA system, used to prepare complex chemotherapy treatments, will help to prevent errors and free up pharmacists’ and nurses’ time,” said Oswald. “That kind of accuracy will bring much-needed comfort to Manitoba families dealing with cancer.”
The advanced RIVA technology performs multiple checks to ensure dose accuracy and appropriate mixing of chemotherapy drugs. RIVA systems in operation around the world have already prepared nearly two million doses safely and accurately. CancerCare Manitoba will become the third facility in Canada to install the high-tech RIVA system.
“This state-of-the-art technology prepares chemotherapy drugs safely and improves accuracy in a clean and contained environment,” said Dr. Dhali Dhaliwal, CEO, CancerCare Manitoba. “The benefits to cancer patients in terms of safety and peace of mind are immeasurable, and the implementation of this technology reinforces CancerCare Manitoba’s position as a national leader in cancer treatment, including chemotherapy safety.”
The new RIVA system at CancerCare, along with the sophisticated software and ongoing support, is valued at nearly $2.5 million. RIVA was developed by Intelligent Hospital Systems, a Winnipeg‑based global health-care technology company that has doubled its local workforce in just a few years.
“This investment is part of the Manitoba government’s plan for steady and strong economic growth that expands our capacity to compete internationally,” said Bjornson. “The fact that this technology, developed right here in Winnipeg, will be used to help Manitoba families when they need it most, makes this especially good news for our province.”
Intelligent Hospital Systems president and CEO Dr. Niels Erik Hansen congratulated the Manitoba government on taking this step.
“RIVA provides an important safeguard for patient care when there simply is no room for error; it sets a new standard for patient and medication safety,” said Hansen. “We are delighted that the Manitoba government is implementing this important technology at CancerCare, while also helping to support the growth of a hometown Manitoba company in Canadian and international markets.”
The RIVA system is expected to be operational at CancerCare Manitoba’s Health Sciences Centre location by the end of summer.
Oswald also noted the Manitoba government and the CancerCare Manitoba Foundation supported the acquisition of the new system.
June 13, 2013
NEW TECHNOLOGY WILL ENSURE SAFETY OF CHEMOTHERAPY DRUGS FOR MANITOBANS WHO NEED THEM
– – –Advanced, High-tech System will Reduce Risk of Error, Increase Productivity: Oswald, Bjornson
“The new RIVA system, used to prepare complex chemotherapy treatments, will help to prevent errors and free up pharmacists’ and nurses’ time,” said Oswald. “That kind of accuracy will bring much-needed comfort to Manitoba families dealing with cancer.”
The advanced RIVA technology performs multiple checks to ensure dose accuracy and appropriate mixing of chemotherapy drugs. RIVA systems in operation around the world have already prepared nearly two million doses safely and accurately. CancerCare Manitoba will become the third facility in Canada to install the high-tech RIVA system.
“This state-of-the-art technology prepares chemotherapy drugs safely and improves accuracy in a clean and contained environment,” said Dr. Dhali Dhaliwal, CEO, CancerCare Manitoba. “The benefits to cancer patients in terms of safety and peace of mind are immeasurable, and the implementation of this technology reinforces CancerCare Manitoba’s position as a national leader in cancer treatment, including chemotherapy safety.”
The new RIVA system at CancerCare, along with the sophisticated software and ongoing support, is valued at nearly $2.5 million. RIVA was developed by Intelligent Hospital Systems, a Winnipeg‑based global health-care technology company that has doubled its local workforce in just a few years.
“This investment is part of the Manitoba government’s plan for steady and strong economic growth that expands our capacity to compete internationally,” said Bjornson. “The fact that this technology, developed right here in Winnipeg, will be used to help Manitoba families when they need it most, makes this especially good news for our province.”
Intelligent Hospital Systems president and CEO Dr. Niels Erik Hansen congratulated the Manitoba government on taking this step.
“RIVA provides an important safeguard for patient care when there simply is no room for error; it sets a new standard for patient and medication safety,” said Hansen. “We are delighted that the Manitoba government is implementing this important technology at CancerCare, while also helping to support the growth of a hometown Manitoba company in Canadian and international markets.”
The RIVA system is expected to be operational at CancerCare Manitoba’s Health Sciences Centre location by the end of summer.
Oswald also noted the Manitoba government and the CancerCare Manitoba Foundation supported the acquisition of the new system.
- 30 -
No comments:
Post a Comment